616
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Treating intra-thyroid parathyroid adenoma by radiofrequency is a valuable alternative to hemithyroidectomy

, ORCID Icon, & ORCID Icon
Article: 2282935 | Received 25 Aug 2023, Accepted 09 Nov 2023, Published online: 21 Nov 2023

References

  • Bilezikian JP, Silverberg SJ, Bandeira F, et al. Management of primary hyperparathyroidism. J Bone Miner Res. 2022;37(11):2391–2403. doi: 10.1002/jbmr.4682.
  • Treglia G, Trimboli P, Huellner M, et al. Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods. Minerva Endocrinol. 2018;43(2):133–143. doi: 10.23736/S0391-1977.17.02685-2.
  • Piccardo A, Trimboli P, Rutigliani M, et al. Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging. 2019;46(3):766–775. doi: 10.1007/s00259-018-4147-4.
  • Imperiale A, Bani J, Bottoni G, et al. Does 18F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism? Front Med. 2023;10:1148287. doi: 10.3389/fmed.2023.1148287.
  • Castellana M, Virili C, Palermo A, et al. Primary hyperparathyroidism with surgical indication and negative or equivocal scintigraphy: safety and reliability of PTH washout. A systematic review and meta-analysis. Eur J Endocrinol. 2019;181(3):245–253. doi: 10.1530/EJE-19-0160.
  • Ha EJ, Baek JH, Baek SM. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol. 2020;21(12):1383–1392. doi: 10.3348/kjr.2020.0037.
  • Gowrishankar SV, Bidaye R, Das T, et al. Intrathyroidal parathyroid adenomas: scoping review on clinical presentation, preoperative localization, and surgical treatment. Head Neck. 2023;45(3):706–720. doi: 10.1002/hed.27287.
  • Hao Y, Lei Z, Shi N, et al. Radiofrequency ablation of parathyroid glands to treat a patient With hypercalcemia caused by a novel inactivating mutation in CaSR. Front Endocrinol. 2021;12:743517. doi: 10.3389/fendo.2021.743517.
  • Khandelwal AH, Batra S, Jajodia S, et al. Radiofrequency ablation of parathyroid adenomas: safety and efficacy in a study of 10 patients. Indian J Endocrinol Metab. 2020;24(6):543–550. doi: 10.4103/ijem.IJEM_671_20.
  • Chai HH, Zhao Y, Zeng Z, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for primary hyperparathyroidism: a prospective study. Korean J Radiol. 2022;23(5):555–565. doi: 10.3348/kjr.2021.0716.
  • Peng CZ, Chai HH, Zhang ZX, et al. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation. Int J Hyperthermia. 2022;39(1):490–496. doi: 10.1080/02656736.2022.2047231.
  • Appelbaum L, Goldberg SN, Ierace T, et al. US-guided laser treatment of parathyroid adenomas. Int J Hyperthermia. 2020;37(1):366–372. doi: 10.1080/02656736.2020.1750712.
  • Kandil E, Haidari M, Issa PP, et al. Radiofrequency ablation of an intrathyroidal parathyroid adenoma with intraoperative parathyroid hormone monitoring: a case report of a novel technique. Gland Surg. 2023;12(5):704–709. doi: 10.21037/gs-22-733.
  • Deandrea M, Trimboli P, Mormile A, et al. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation. Eur Radiol. 2021;31(7):5189–5197. doi: 10.1007/s00330-020-07532-y.
  • Albano D, Durmo R, Bertagna F, et al. 18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer. Endocrine. 2019;63(3):531–536. doi: 10.1007/s12020-018-01832-6.
  • Shin JH, Baek JH, Ha EJ, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:919650–919657. doi: 10.1155/2012/919650.
  • Bini F, Trimboli P, Marinozzi F, et al. Treatment of benign thyroid nodules by high intensity focused ultrasound (HIFU) at different acoustic powers: a study on in-silico phantom. Endocrine. 2018;59(3):506–509. doi: 10.1007/s12020-017-1350-1.